Press Releases | Healthcare Times Denmark

Explore more publications!

Press Releases

Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

Apr. 1, 2026

Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

MENAFN

Owner: Sawsan Dababneh

MENAFN

Owned By	Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Jordan, Amman
Owner Country	Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035

Mar. 31, 2026

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035

EIN Presswire

12 hours ago

Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States

GlobeNewswire, Inc.

Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks

Apr. 1, 2026

Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks

MENAFN

Owner: Sawsan Dababneh

MENAFN

Owned By	Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Jordan, Amman
Owner Country	Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Mar. 31, 2026

Total number of shares and voting rights in Zealand Pharma as of March 31, 2026

GlobeNewswire, Inc.

Mar. 31, 2026

MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

GlobeNewswire, Inc.

Global SGLT2 Inhibitors Market Led by North America as AstraZeneca and Boehringer Ingelheim Expand Drugs

14 hours ago

Global SGLT2 Inhibitors Market Led by North America as AstraZeneca and Boehringer Ingelheim Expand Drugs

EIN Presswire

MISTR Founder Tristan Schukraft Joins the Producing Team of Titanique

13 hours ago

MISTR Founder Tristan Schukraft Joins the Producing Team of Titanique

GlobeNewswire, Inc.

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

Mar. 23, 2026

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

GlobeNewswire, Inc.

Mar. 26, 2026

Resolutions from Zealand Pharma's Annual General Meeting 2026

GlobeNewswire, Inc.

Older Adults Health Supplements Market to Reach USD 351.1 Billion by 2036 Amid Rising Global Ageing Demand

Mar. 26, 2026

Older Adults Health Supplements Market to Reach USD 351.1 Billion by 2036 Amid Rising Global Ageing Demand

EIN Presswire

Mar. 25, 2026

VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management

GlobeNewswire, Inc.

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Mar. 24, 2026

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

GlobeNewswire, Inc.

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer

Mar. 17, 2026

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer

EIN Presswire

Mar. 24, 2026

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

GlobeNewswire, Inc.

Mar. 23, 2026

Groundbreaking Danish research project launches to cure Parkinson’s disease

GlobeNewswire, Inc.

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

Mar. 23, 2026

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

GlobeNewswire, Inc.

Mar. 23, 2026

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851

GlobeNewswire, Inc.

Mar. 19, 2026

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

GlobeNewswire, Inc.

Mar. 20, 2026

Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer’s candidate at AD/PD™ 2026

GlobeNewswire, Inc.